Kristina Gutschmidt
Munich, BY 80336, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Nociceptive pain in late-onset Pompe disease: prevalence, distribution, and clinical correlates.
Journal: Journal of neurology
Published: June 10, 2026
Efficacy and safety of respiratory strength and endurance training in patients with myotonic dystrophy type 1 (DM1): a randomized controlled trial.
Journal: Journal of neurology
Published: June 06, 2025
The assistive gait devices and their implementation in activities of daily living for patients with neuromuscular disease: A systematic review and meta-analysis.
Journal: Journal of neuromuscular diseases
Published: February 20, 2025
Evaluation of myotonometry for myotonia, muscle stiffness and elasticity in neuromuscular disorders.
Evaluation of myotonometry for myotonia, muscle stiffness and elasticity in neuromuscular disorders.
Journal: Journal of neurology
Published: May 02, 2023
Suitability of the Respicheck questionnaire and Epworth sleepiness scale for therapy monitoring in myotonic dystrophy type 1.
Journal: Neuromuscular disorders : NMD
Published: March 28, 2023
Prediction of respiratory impairment in myotonic dystrophies using the 'Respiratory involvement symptom checklist' (Respicheck).
Journal: Neuromuscular disorders : NMD
Published: February 21, 2023
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease.
Journal: Journal of neurology
Published: November 22, 2020
Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1.
Journal: Neurology. Genetics
Published: September 23, 2020
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa.
Journal: Journal of neurology
Published: September 10, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026